Posted by pharmrep on July 31, 2002, at 23:35:51
In reply to Re: continued info » pharmrep, posted by Ritch on July 31, 2002, at 23:10:57
Maybe...if Lilly can get their manufacturing out of the toilet. They are in trouble right now. read up on them on your favorite news site...yahoo, hoovers, etc..their stock is in the dumps and rumors of a buyout are all over. they have a decent pipeline of products on the way, but if they cant get out the QA/manufacturing disaster they are in...who knows how long it will be. My Lilly rep friend says it was suppossed to be out in spring, and now...maybe 1+ years away. Anyway, with the Freemantle study about other sites not being better, it will be interesting to see how this new drug can perform. It's a shame that the company who introduced ssri's and got us out of tricyclics is having trouble. They need to get it together fast, or all credibility will be lost. As far as side effects...naseua is common with nearly any new med, but the activating and gastrointestinal side effects for all the ssri's (and other classes) do vary greatly from each other. Only a few s/e are common between them.
poster:pharmrep
thread:109458
URL: http://www.dr-bob.org/babble/20020731/msgs/114724.html